COMP <GO>
OTLK vs LENZ // FORWARD P/E MULTIPLE
Outlook Therapeutics Inc. (NASDAQ) VS. LENZ Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: OTLK 2
— LENZ 3
■ METRIC PARITY
LAST: $0.47 (-5.15%) • MKT CAP: $120.1M
forward-pe
—
LAST: $3.05 (-12.61%) • MKT CAP: $109.7M
forward-pe
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OTLK VS. LENZ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OTLK | LENZ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 4.00% | 96.00% | -92.00 | LENZ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -27.80% | -7.20 | LENZ | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 2.19 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 3/9 | -1.00 | LENZ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 37.0 | 35.8 | +1.22 | OTLK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $120.1M | $109.7M | $10.5M | OTLK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OTLK REV | LENZ REV | OTLK GROSS % | LENZ GROSS % | OTLK FCF | LENZ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.4M | $19.1M | 4.0% | 97.8% | -$51.8M | -$70.0M |
| FY 2024 | $0 | $0 | — | — | -$68.8M | -$59.9M |
| FY 2023 | $0 | $0 | — | — | -$43.0M | -$60.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OTLK // BETA —
LENZ // BETA —